Brown KK - Search Results

1

BUILD-1: a randomized placebo-controlled trial of bosentan in idiopathic pulmonary fibrosis.

King TE Jr, Behr J, Brown KK, du Bois RM, Lancaster L, de Andrade JA, Stähler G, Leconte I, Roux S, Raghu G. King TE Jr, et al. Among authors: brown kk. Am J Respir Crit Care Med. 2008 Jan 1;177(1):75-81. doi: 10.1164/rccm.200705-732OC. Epub 2007 Sep 27. Am J Respir Crit Care Med. 2008. PMID: 17901413 Clinical Trial.

2

Respiratory bronchiolitis-associated interstitial lung disease: radiologic features with clinical and pathologic correlation.

Park JS, Brown KK, Tuder RM, Hale VA, King TE Jr, Lynch DA. Park JS, et al. Among authors: brown kk. J Comput Assist Tomogr. 2002 Jan-Feb;26(1):13-20. doi: 10.1097/00004728-200201000-00003. J Comput Assist Tomogr. 2002. PMID: 11801899

3

Nonspecific interstitial pneumonitis as the sole histologic expression of hypersensitivity pneumonitis.

Vourlekis JS, Schwarz MI, Cool CD, Tuder RM, King TE, Brown KK. Vourlekis JS, et al. Among authors: brown kk. Am J Med. 2002 Apr 15;112(6):490-3. doi: 10.1016/s0002-9343(02)01046-x. Am J Med. 2002. PMID: 11959061 No abstract available.

4

Changes in clinical and physiologic variables predict survival in idiopathic pulmonary fibrosis.

Collard HR, King TE Jr, Bartelson BB, Vourlekis JS, Schwarz MI, Brown KK. Collard HR, et al. Among authors: brown kk. Am J Respir Crit Care Med. 2003 Sep 1;168(5):538-42. doi: 10.1164/rccm.200211-1311OC. Epub 2003 May 28. Am J Respir Crit Care Med. 2003. PMID: 12773325

5

A placebo-controlled trial of interferon gamma-1b in patients with idiopathic pulmonary fibrosis.

Raghu G, Brown KK, Bradford WZ, Starko K, Noble PW, Schwartz DA, King TE Jr; Idiopathic Pulmonary Fibrosis Study Group. Raghu G, et al. Among authors: brown kk. N Engl J Med. 2004 Jan 8;350(2):125-33. doi: 10.1056/NEJMoa030511. N Engl J Med. 2004. PMID: 14711911 Free article. Clinical Trial.

6

Prognosis in idiopathic pulmonary fibrosis.

Thabut G, Fournier M, Collard HR, Brown KK. Thabut G, et al. Among authors: brown kk. Am J Respir Crit Care Med. 2004 May 1;169(9):1075-6; author reply 1076. doi: 10.1164/ajrccm.169.9.962. Am J Respir Crit Care Med. 2004. PMID: 15107309 No abstract available.

7

The effect of pulmonary fibrosis on survival in patients with hypersensitivity pneumonitis.

Vourlekis JS, Schwarz MI, Cherniack RM, Curran-Everett D, Cool CD, Tuder RM, King TE Jr, Brown KK. Vourlekis JS, et al. Among authors: brown kk. Am J Med. 2004 May 15;116(10):662-8. doi: 10.1016/j.amjmed.2003.12.030. Am J Med. 2004. PMID: 15121492

8

Combined corticosteroid and cyclophosphamide therapy does not alter survival in idiopathic pulmonary fibrosis.

Collard HR, Ryu JH, Douglas WW, Schwarz MI, Curran-Everett D, King TE Jr, Brown KK. Collard HR, et al. Among authors: brown kk. Chest. 2004 Jun;125(6):2169-74. doi: 10.1378/chest.125.6.2169. Chest. 2004. PMID: 15189938

9

Interstitial lung disease: clinical evaluation and keys to an accurate diagnosis.

Raghu G, Brown KK. Raghu G, et al. Among authors: brown kk. Clin Chest Med. 2004 Sep;25(3):409-19, v. doi: 10.1016/j.ccm.2004.05.007. Clin Chest Med. 2004. PMID: 15331183 Review.

10

Medical treatment for pulmonary fibrosis: current trends, concepts, and prospects.

Brown KK, Raghu G. Brown KK, et al. Clin Chest Med. 2004 Dec;25(4):759-72, vii. doi: 10.1016/j.ccm.2004.08.003. Clin Chest Med. 2004. PMID: 15564021 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

456 results

Search Page

Filters